Tag: Regeneron Pharmaceuticals
Oral Vaccine Boosts COVID Immunity: study conducted on nonhuman primates is published in the journal Vaccine
ROCHESTER, Minn., April 6, 2022 (SEND2PRESS NEWSWIRE) -- Vyriad, Inc., a clinical-stage biotechnology company developing oncolytic virus therapies to treat a wide range of cancers, today announced results confirming the activity of an oral vaccine formulation for boosting immunity against SARS-CoV-2. The full study conducted on nonhuman primates is published in the journal Vaccine.
NY Gov. Cuomo Announces Regeneron Pharmaceuticals to Create 400 New Jobs in Hudson Valley
ALBANY, N.Y. /New York Netwire/ -- Today, NY Governor Andrew M. Cuomo and Regeneron Pharmaceuticals, Inc., a world leader in biopharmaceutical research and development,...
NY Governor Cuomo Announces Regeneron Pharmaceuticals to Expand in The Capital Region
ALBANY, N.Y. /New York Netwire/ -- Governor Andrew M. Cuomo today announced that Regeneron Pharmaceuticals, Inc. will invest nearly $70 million to expand its...
